CD4 and cancer: In cancers that CXCL13 harbor favorable prognosis, one study reported that CXCL13 was associated with better overall survival and positively correlated with infiltration of six immune cells (B cell, CD8+T cells, CD4+T cells, macrophages, neutrophils, dendritic cells) in SKCM (21).